ARCHIVES

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

ACCC Annual Meeting To Study Organizing Community Care

January 26, 1979

Flow Lab Lands Top Virology Contract – $1.9 Mil.

February 21, 1975

Bristol To Support Grants For Studies On Drug Resistance

June 26, 1987

New NCAB Appointees Include Some Old Hands; Korn Renamed Chairman

May 13, 1988

NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers

September 16, 2011

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

April 3, 1992